Veracyte cuts target price to $46 from $69
VCYT•Needham cut its target price for Veracyte to $46 from $69.
Related News
BBVA issues $2.05 billion in senior non-preferred debt across three tranches
BBVA•
D.A. Davidson raises Procore Technologies target price to $70 from $56
PCOR•
Diageo CEO gets quarterly sales boost in first stage of turnaround
DEO•
Cava Group: RBC cuts target price to $80 from $85
CAVA•
ADNOC Gas and Baker Hughes sign strategic collaboration agreement
BKR•